Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  H. Lundbeck A/S    LUN   DK0010287234

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo H. Lundbeck A/S
Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases

H. Lundbeck A/S engages in the research, development, and market of pharmaceutical products for the treatment of psychiatric and neurological disorders.

It operates through the following geographical segments: Europe, the Unites States of America, and International Markets.

Its product portfolio targets the following diseases: Alzheimer's, depression, Parkinson's, Schizophrenia, alcohol dependence, anxiety, bipolar disorder, epilepsy, and Huntington's.

The company was founded by Hans Lundbeck on August 14, 1915 and is headquartered in Valby, Denmark.

Number of employees : 4 983 persons.
Sales per Businesses
20152016Delta
DKK (in Million)%DKK (in Million)%
Other Pharmaceuticals3,19522.1%2,99419.2% -6.29%
Cipralex/Lexapro2,59117.9%2,51816.1% -2.82%
Xenazine2,20115.2%1,57110.1% -28.62%
Onfi1,75712.1%2,40915.4% +37.11%
Azilect1,45710.1%---
Sabril985.006.8%1,3428.6% +36.24%
Abilify Maintena669.004.6%1,1147.1% +66.52%
Other635.004.4%668.004.3% +5.2%
Brintellix/Trintellix629.004.3%1,1057.1% +75.68%
Northera475.003.3%1,0877% +128.84%
Rexulti--826.005.3%-
Sales per Regions
20152016Delta
DKK (in Million)%DKK (in Million)%
United States6,35343.9%8,40453.8% +32.28%
Rest of Europe3,86926.7%2,89118.5% -25.28%
International3,82726.5%3,99325.6% +4.34%
Global518.003.6%325.002.1% -37.26%
Denmark27.000.2%21.000.1% -22.22%
Managers
NameAgeSinceTitle
Kåre Schultz562015President & Chief Executive Officer
Lars Søren Rasmussen582013Chairman
Anders Götzsche502007CFO & Executive VP-Information Technology
Lars Bang551988EVP-Supply Operations & Engineering
Anders Gersel Pedersen MD, PhD662000Executive Vice President-Research & Development
Jørn Møller Mayntzhusen, MBA512002Director & Senior Manager-Supply Optimisation
Mona Elisabeth Elster551994Director
Terrie Curran482014Independent Director
Henrik Sindal Jensen, PhD482004Director
Lene Skole-Sørensen582015Deputy Chairman
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 197,619,721 59,643,877 30.2% 271,187 0.1% 30.2%
Shareholders
NameEquities%
Lundbeck Foundation 137,351,918 69.5%
OppenheimerFunds, Inc. 4,738,551 2.40%
Wellington Management Co. LLP 3,614,969 1.83%
TIAA-CREF Investment Management LLC 3,009,078 1.52%
Norges Bank Investment Management 1,963,697 0.99%
Teachers Advisors, Inc. 1,911,205 0.97%
Templeton Global Advisors Ltd. 1,567,831 0.79%
Oddo Meriten Asset Management SA 1,466,528 0.74%
Nordea Investment Management AB (Denmark) 1,438,881 0.73%
The Vanguard Group, Inc. 1,193,123 0.60%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
H. LUNDBECK A/S0.14%8 138
JOHNSON & JOHNSON3.17%323 362
ROCHE HOLDING LTD.4.69%210 814
PFIZER INC.3.51%204 018
NOVARTIS AG3.91%202 998
MERCK & CO., INC.11.08%180 289
SANOFI5.97%111 739
GLAXOSMITHKLINE PLC4.96%99 883
BAYER AG7.43%93 467
ALLERGAN PLC17.78%92 776
BRISTOL-MYERS SQUIBB C..-6.59%91 232
ELI LILLY AND CO9.30%88 746
ABBOTT LABORATORIES16.35%77 144
ASTRAZENECA PLC3.55%72 599
NOVO NORDISK A/S-3.02%71 157
SHIRE PLC1.69%54 627
TAKEDA PHARMACEUTICAL ..8.00%36 566
TEVA PHARMACEUTICAL IN..-3.18%36 414
ASTELLAS PHARMA INC-5.10%29 442
MYLAN NV10.22%22 501
CHUGAI PHARMACEUTICAL ..14.90%19 114
Sector Pharmaceuticals - NEC
H. Lundbeck A/S : Connections
Fonden Lundbeck International Neuroscience Foundation
Rosborg Møbler A/S
Danish Society of Medical Oncology
Confederation of Danish Industry
Fertin Pharma A/S
International Association for the Study of Lung Cancer
Lundbeckfond Invest A/S
Danish Society of Internal Medicine
Tryg Forsikring A/S
The British Chambers of Commerce
Coloplast Ejendomme A/S
Lfi Equity A/S
Lundbeck Pharma A/S
LEGO A/S
Lundbeck Cognitive Therapeutics A/S
American Chamber of Commerce Executives, Inc.
European Society for Medical Oncology
Coloplast Danmark A/S
American Society of Clinical Oncology
Company contact information
9 Ottiliavej
DK 2500 Valby, Copenhagen
Denmark

Phone : +45 36 30 13 11
Fax : +45 36 30 19 40
Internet : http://www.lundbeck.com
Markets and indexes
- NASDAQ OMX nordic Kopenhagen
- Main Market Large
- OMXC 20 /
Stock Exchange Codes
- ISIN Code :  DK0010287234
- Bloomberg Code :  LUN:DC
- Reuters Code :  LUN.CO
- Datastream Code :  DK:LUND
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem